draft program - may 4th & 5th...

Draft program, “Societal impact of pain”, May 4& 5th 2010, Hotel Dolce La Hulpe, Brussels 24.03.2010 /29

Draft Program

May 4th & 5th 2010 Hotel Dolce La Hulpe, Brussels

Organized by EFIC®, thanks to the support and sponsoring of


Contents Pain care as a quality indicator for health care systems.................................................. 3 The Symposium “Societal Impact of Pain”....................................................................... 4 Draft program - May 5th 2010.......................................................................................... 7

Workshop 1, Prevalence & epidemiology................................................................... 16 Workshop 2, Evidence in pain therapy from a societal perspective ........................... 17 Workshop 3, Impact of pain on the society ................................................................ 18 Workshop 4, Health economic models on pain treatment .......................................... 19 Workshop 5, Cost related to pain............................................................................... 20 Workshop 6, Light house projects (“best practice”).................................................... 22

Organisation .................................................................................................................. 23 Program Steering Committee..................................................................................... 23 Scientific responsibility ............................................................................................... 23 Meeting Logistics ....................................................................................................... 23 Sponsor...................................................................................................................... 23

Registration ................................................................................................................... 24 Participant registration............................................................................................ 24 MDEON visumnummer........................................................................................... 24 Accommodation...................................................................................................... 24 Speaker registration ............................................................................................... 24

Speaker Information................................................................................................... 25 Language ............................................................................................................... 25

Poster presentation Information..................................................................................... 26 Exhibitor Opportunities .................................................................................................. 26 The venue: Dolce La Hulpe ........................................................................................... 27 About EFIC.................................................................................................................... 28


Pain care as a quality indicator for health care systems Pain is possibly the world's most common reason for initially using health care services: from the patient’s perspective: “if you are feeling pain, you go to the doctor”1 and from the perspective of the health care systems: “if you go to the doctor, you are most probably suffering from pain”. Pain is a major symptom in many medical conditions, significantly interfering with a person's quality of life and general functioning. As such expenses related to pain represent a significant proportion of total health care costs. Pain is the third most common healthcare problem after heart disease and cancer with large impact on quality of life and societal costs worldwide2. As the efficient management of “expensive” diseases, it is becoming of higher priority for strategic decision makers costs and pain-related health care outcomes are moving increasingly into the focus of budget holders and policy makers. Because of the high prevalence of pain, for many European health care systems pain treatment can be considered as an indicator to compare and assess the quality of their health care systems. This hypothesis leads to the following questions: • How are the demographics and dynamics of the insured population? • Which diseases generate significant costs? • Which costs are related to pain and pain therapy? • Where are possibilities for improvement of pain management? • How does the cost management approach of the health care system impact pain

care? • How does pain therapy correlate with the overall objectives of the health care

systems? While in most countries some very interesting projects have been initiated investigating the economic factors related to the burden of pain to patients and the society, the knowledge gained and management instruments developed locally are still sparsely shared amongst health care authorities and policy makers throughout Europe. The symposium “Societal impact of pain” intends to be instrumental in finding answers and sharing knowledge on these issues.

1 Pain of any type is the most common reason for physician consultation in the United States, prompting half of all Americans to seek medical care annually; National Pain Education Council (NPED) : http://www.npecweb.org/aboutnpec.asp?id=22&selMenu=2,8 Accessed 2009.02.Nov. 2 National Pain Education Council (NPED). http://www.npecweb.org/aboutnpec.asp?id=22&selMenu=2,8. Accessed 2009.02.Nov.


The Symposium “Societal Impact of Pain” This symposium aims to describe the problem and deliver the facts and issues around the definition, prevalence, demographics, quality measurement, cost and resources related to the impact of pain on society. Several studies focusing on the factors affecting the cost and quality of pain therapy will be presented and discussed. The different views and solutions will allow building a network on the issues related to the “Societal Impact of Pain” in the EU from the health care systems perspective. The two-days symposium will take place in Brussels in May 2010 and is organized by EFIC®, thanks to the support and sponsoring of Grünenthal. Approximately 100 strategic decision makers on pain-therapy-related issues and with responsibility for healthcare budgets from different European countries will be invited in order to discuss factors affecting the costs of pain therapy, benchmark indicators and future perspectives in workshops. The findings and results will be presented in both plenary sessions and in a publication of the proceedings. The scientific framework of the symposium has been realized under the responsibility of the EFIC®.


Draft program - May 4th 2010 Venue: Hotel la Hulpe Brussels 10:00 Registration 12:00 Get together Podium presentations –

Symposium president and chair: Giustino Varrassi Co moderation Albrecht Kloepfer

13:00 The goals of this symposium

Giustino Varrassi

President EFIC Italy confirmed

13:15 Pain as a quality indicator for health care systems

Alberto Grua

Grünenthal Germany confirmed

13:30 Chronic pain: a disease without a name

Serdar Erdine

President World Institute of Pain

Turkey confirmed

14:00 The Need For A Whole Systems Perspective

Ceri Philips

School of health science, Swansea University

UK confirmed

14:30 The impact of pain according to consumers and patients; results of a survey in big 5 EU countries

Paul Langley

University of Minnesota US confirmed

15:00 Coffee 15:15 Health and

Pain in the European Union

Isabel De La Mata

EU Health & Consumers Directorate General - DG SANCO Principal Adviser - Public health and risk assessment

EU confirmed

15:45 Interventional therapeutic strategies for the treatment of pain

José De Andrés

President of the Foundation for study and treatment of pain of the Valencian community

Spain confirmed

16:15 Innovation; Meindert Programme Director UK confirmed


pain or value Boysen Technology Appraisals, NICE

16:45 The informational gap between physicians and their patients.

Lise Rochaix

French National Health Authority (HAS, Haute Autorité de Santé)

France confirmed

17:15 Therapeutic strategies for the treatment of pain

Paolo Daniele Siviero

Direttore, Ufficio Centro Studi Agenzia Italiana del Farmaco (AIFA)

Italy confirmed

17:45 Are we adequately equipped to asses pain therapies

Ken Paterson

Scottish Medicines Consortium (SMC)

Scotland confirmed

18:15 Discussion 18:30 End day 1 20:00 Dinner 20:30 22:00 Dinner end


Draft program - May 5th 2010 Parallel Workshops 08:30 Workshop 1

Chairman: Per Hansson

Karolinska University Hospital Honorary Secretary & member of the EFIC® executive board

Sweden confirmed

Secretary: Alain Serrie

Chef de service, Département Médecine de la Douleur Médecine Palliative et Urgences Céphalées

France confirmed

Moderator: Isabelle Durand Zaleski

Head of hospital service (evaluation and studies) Henri Mondor, Créteil member of “Haut Conseil de Santé publique” (HCSP)

France confirmed

Prevalence and epidmiology

Reporter: Narinder Rawal

Orebro University Hospital

Sweden confirmed

Analyses of types and costs of pain - based on 6 million insured persons

Cornelius Erbe

Gesundheitsökonomie, Versorgungsmanagement DAK-Hauptgeschäftsstelle

Germany confirmed

Results of a literature review on the epidemiology of chronic pain in the EU

Jos Kleijnen Kleijnen Systematic Reviews Ltd.

The Nether-lands

confirmed

Chronic pain in Austria

Wilfried Ilias President Austrian pain society

Austria confirmed

Prevalence and socio-economic

José Castro Lopes

Faculty of Medicine of the University of Porto

Portugal confirmed


impact of pain in Portugal

President of the National Observatory for Pain

Pain in oncology

Ana Casas Oncology Unit Hospital Virgen del Rocio. Sevilla

Spain confirmed

Prevalence of neuropathic pain in Poland.

Jan Dobrogowski

Department of Pain Research and Therapy Jagiellonian University

Poland confirmed

08:30 Workshop 2 Ken Paterson Scottish Medicines

Consortium (SMC) Scotland confirmed

Secretary: Wil Toenders

Toenders De Groot adviseurs, prevous Secretary, Pharmaceutical reimbursement Committee of CVZ, Netherlands

The Nether-lands

confirmed

Moderator: Yves Henrotin

Institut de Pathologie, Unité d'Exploration du Métabolisme de l'Os et du Cartilage Vice President, spine section in French Rheumatology Society (SFR)

Belgium confirmed

Evidence in pain therapy from a societal perspective

Reporter: Marja Kuijpers

College voor zorgverzekeringen (CVZ)

The Nether-lands

requested

Can we ensure future innovations on the societal impact of pain

Martin van der Graaff

Secretary, Pharmaceutical reimbursement Committee of CVZ, Netherlands

The Nether-lands

confirmed

Evidence in pain or pain in Evidence?

Norbert Schmacke

Arbeits- und Koordinierungsstelle Gesundheitsversorgungsforschung

Germany confirmed

Practice of benefit

Matthias Perleth

Abteilung Fachberatung Medizin

Germany confirmed


assessment of pain relieving medications

Gemeinsamer Bundesausschuss

Pain undertreat-ment in oncological patients

Giovanni Apolone

Istituto di Ricerche Farmacologiche "Mario Negri"

Italy confirmed

"WHO Treatment Guidelines on Pain: Processes, Status, Challenges"

Barbara Milani

Technical Officer Access to Controlled Medications Programme Department of Essential Medicines and Pharmaceutical Policies World Health Organization

WHO confirmed

Measuring Functionality as Treatment Outcome in Low Back Pain

Thomas R. Tölle

Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS)

Germany confirmed

08:30 Workshop 3 Chairman: Robert Schlögel

Bundesministerium für Gesundheit Verbrauchergesund-heit und Gesundheits-prävention

Austria requested

Secretary: Gottfried Endel

Hauptverband der Österreichischen Sozialversicherung-sträger

Austria confirmed

Moderator: Albrecht Kloepfer

Büro für gesundheitspolitische Kommunikation

Germany confirmed

Impact of pain on the society

Reporter: Norman Evans

Imperial College, London Healthcare Trust

UK confirmed

Citizens rights for pain treatment in

Antonio Gaudioso

Cittadinanza attiva Italy confirmed


Italy The impact

of pain from the patient perspective

Joana Gabriele

President of the Spanish Patients Association

Spain confirmed

Pain and Rehabilitation

Roberto Casale

“Salvatore Maugeri” Foundation, IRCCS Montescano, Pavia

Italy confirmed

Why the National Pain Audit is important

Benjamin Ellis

The Chief Medical Officer Office, Department of Health

UK requested

Pain in health care politics

Anouchka van Miltenburg

VVD Tweede Kamer Netherlands

requested

Pain and family

Werner Kerschbaum

Deputy Secretary General, Österreichischen Roten Kreuz

Austria confirmed

pain management in practice

Michel Vanhalewyn

general coördinator Sociéte scientifique de Médecine générale (SSMG)

Belgium confirmed

Charter of Rights for people living with Chronic Pain

Gina Plunkett Vice Chairperson of the Chronic Pain Association

Ireland confirmed

Quality of`life after pain treatment in patients with fybromialgia

Emilia Altarriba

President of the Foundation of Fybromyalgia

Spain confirmed

08:30 Workshop 4 Chairman: Eli Alon

University of Zürich, Member EFIC® Executive Board, Honorary Treasurer

Swiss confirmed

Secretary: Francis Fagnani

Health Economist, Director CEMKA-EVAL

France confirmed

Moderator: Christoph Vauth

KKH-Allianz, Gesetzliche Krankenversicherung

Germany confirmed

Health economic models in pain treatment

Reporter: N.N.

Not requested


yet The Social

Economic Costs of Chronic Pain in Spain.

Renata Villoro

Project Manager Max Weber Institute. Master in H.E. York University.

Spain confirmed

How to asses the economic cost of pain in Denmark?

Morten Andreas Hjulsager

Danish National board of health

Denmark confirmed

Issues in the Health Technology Assessment of Treatments for Pain

Ailsa Brown Principal Health Economist, Scottish Medicines Consortium (SMC)

Scotland confirmed

Why do we need an ICD10 code for chronic pain?

Reinhard Thoma

President, Professional Association of pain specialists in Germany (BVSD)

Germany confirmed

Overview of objectives and methodology of ongoing real world studies

Ian Power Anaesthesia, Critical Care & Pain Medicine, School of Clinical Sciences and Community Health

UK confirmed

medico-legal medicine and economic challenges in pain medicine

Eric Jensen Chefarzt MEDAS Medizinisches Zentrum Römerhof

Swiss confirmed

Monitoring of pain therapy in local health-care unit

Pietro Giusti Director Pharmacology Padova

Italy confirmed

08:30 Workshop 5 Costs

related to pain

Chairman: Hans-Georg Kress

President Elect of EFIC, Medical University /

Austria confirmed


AKH Vienna Co chairman: Bernard Avouac

Membre de la CEPP (HAS)

France confirmed

Secretary: Ad Rietveld

RJW & Partners Ltd. The Nether-lands

confirmed

Moderator: Livio Garattini

Instituto di Ricerche Farmacologiche Mario Negri

Italy confirmed

Reporter: N.N.

Not requested yet

The costs of musculoskeletal pain: the need for priority services

Paul J. Watson

University of Leicester UK confirmed

Experience of regione Veneto

Chiara Alberti Group for evaluation of drug efficacy (Unità di Valutazione dell’Efficacia del Farmaco; UVEF) – Verona

Italy requested

Trends in the consumption of opioid analgesics in Spain.

José María Recade

CADIME Coordinator (New Drugs Evaluation Committee, Andalusia)

Spain requested

Importance of Guidelines in pain treatment

Francisco Kovacs

President of Kovacs Foundation

Spain requested

The social cost of painful neuropathy in the 21st century

Magdi Hanna Director of Analgesics & Pain Research Unit (APRU)

UK confirmed

Pharmacoepidemiological aspects on the costs of pain

Eva Zebedin-Brandl

Hauptverband der Österreichischen Sozialversicherung-sträger

Austria confirmed

Cost related Marek Departament Poland requested


to pain in Poland

Twardowski Współpracy Międzynarodowej

08:30 Workshop 6 Chairman: Mary Baker

President - European Federation of Neurological Associations (EFNA)

confirmed

Secretary: Günter Danner

Europavertretung der Deutschen Sozialversicherung

EU confirmed

Moderator: Agis Tsouros

WHO Regional Office for Europe

WHO requested

Light house projects (“best practice”)

Reporter: N.N.

Not requested yet

Societal benefit of multidiciplinary rehabilitation in chronic non-malignant pain patients.

Villy Meineche Schmidt

Tværfagligt Smertecenter / Den private smerteklinik

Denmark confirmed

Pathways of Care for pain

Beverly Collett

Chronic Pain Policy Coalition, International Association for the Study of Pain (IASP)

UK confirmed

What can we learn from insurance data on pain, facts and costs?

Jacob Hofdijk Special Advisor, Chronic Disease Management, Ministry of Health President EFMI

The Netherlands

confirmed

The Italian experience

Guido Fanelli Università di Parma Italy confirmed

Back Pain Survey in Styria – Data basis for a paradigm change?

Ewald Gspurning

Steiermark Austria confirmed

Benefits of Sergi University of patients – Spain confirmed


self-care programs in pain for patients

Blancafort Foundation Josep Laporte, Barcelona. Spain

Role of Regione Toscana in supporting improvements in pain treatment

Galileo Guidi Regions Coordinator Palliative Care

Italy confirmed

“Hospital Sin Dolor” project in Spain

José María Muñoz y Ramón

Deputy Medical Director, Chief of Pain Management Hospital Universitario La Paz – Madrid. Member of the Hospital SIN DOLOR Commission.

Spain confirmed

The planning of pain treatment from the Health Authorities perspective

Manuel Jiménez

Regional Coordinator for the programme against pain in Extremadura

Spain requested

The planning of pain treatment from the Health Authorities perspective

Antonio Torres

Agency of Healthcare Quality, Andalusia

Spain requested

12:00 Lunch Podium presentations

Symposium president and chair: Giustino Varrassi Co moderation Albrecht Kloepfer

13:00 Report of the workshops Chairman: Giustino Varrassi (EFIC) 14:00 The future of

cooperation’s in pain therapy

Norbert Klusen

Chief Executive Officer, TK Krankenkasse

Germany confirmed

14:30 Developing a National Service Framework for

Pete MacKenzie

Scottish Government

Scotland confirmed


chronic pain Lead Clinician for Chronic Pain

15:00 Discussion & summary Chairman: Giustino Varrassi (EFIC) 16:00 end


Workshop 1, Prevalence & epidemiology Measuring the magnitude of the problem In some cases pain may become intractable and develop into a condition called chronic pain, in which pain is no longer considered a symptom but an illness of itself. These cases often develop to having a high budget impact. Some sources estimate pain being one of the top 10 diseases impacting health care budgets. In order to make valid decisions regarding policy and budgets managers need to have a valid data base. This workshop aims to give an overview on the possibilities and short comings of the sources on prevalence and epidemiology currently available for strategic decision making on pain related budgets. Workshop format

• The target audience for this workshop will be epidemiologists, politicians, strategic decision makers and their advisers

• The format will be interactive with different key note speakers

• Following the key note presentations, a facilitated discussion will take place, taking each topic in turn and inviting the audience to come up with ideas and opinions on how to fill the gaps in knowledge and data

Workshop deliverables Based on the workshop, a symposium position paper will be produced that will cover:

• A description of the problem: the impact of chronic pain as a driver of healthcare costs, loss of quality of life and impact on society

• A proposal for next steps that need to be taken to make data available for decision-making


Workshop 2, Evidence in pain therapy from a societal perspective How to generate evidence, relevant to budget holders and policy makers? For most treatments efficacy can be seen as a valid outcome. As pain mostly appears as a major symptom in many medical conditions, while being considered as highly subjective, pain related outcomes are often hard to translate in valid evidence for decision making by health authorities. The symptomatic and personal nature of pain makes it a challenge for health care authorities to reflect pain and its treatment in their decisions. This workshop intends to answer the following questions regarding evidence in pain therapy:

• How to assess the impact of pain on the Quality of life (QoL) of the individual patient and how pain relief really impacts on this?

• What evidence should be available in order to take policy decisions on the benefits of new pain therapies?

• Is it possible to combine the needs of registration and reimbursement authorities in the same clinical trial? Can registration studies also provide information on comparative benefits?

• Which outcome measures are needed and how to identify the right comparative treatment for pain?

• How can we capture the real benefits of new agents in terms of conventional HTA measures such as utility values?

• How to generate evidence from real practice in pain therapy which is important from a societal perspective?

Workshop format

• The target audience for this workshop will be health economists, budget planners, strategic decision makers and their advisers.

• The format will be interactive with diefferent key note speakers.

• Following the key note presentations, a facilitated discussion will take place, taking each topic in turn and inviting the audience to come up with ideas and opinions on how to fill the gaps in knowledge and data.


• A description of the problem: the factors related to the availability and of evidence related to pain and pain treatment.

• A proposal to help authorities to include pain in future decision making.


Workshop 3, Impact of pain on the society Pain is not just a clinical or individually relevant problem. Beyond health policy pain plays a serious macro-economic role in our society, for example due to pain resulting in reductions in productivity, absenteeism and early retirement. At the same time acute pain, chronic pain and pain in palliative care are so present in society that authorities are frequently confronted with the need to take adequate decisions. The workshop "Impact of Pain on society" aims to investigate the broad range social implications of pain on society leading to strategic decisions, not only from a health policy perspective but also in other fields of politics like business, employment or social environment. Workshop format

• The target audience for this workshop will be authorities representing consumers and patients, politicians, health care decision makers and their advisers.

• The format will be interactive with different key note speakers representing various areas within society.



• A multi perspective description of the problem: the impact of chronic pain as a driver of healthcare costs, loss of quality of life and impact on society.

• A proposal for next steps that need to be taken to make data available for decision-making.


Workshop 4, Health economic models on pain treatment Health economic models on the functioning of the health care system and the private and social causes of health-affecting behaviours are a frequently used as a base for decision making. Few models for pain are available. This leads to a variety of questions like:

• How to measure the impact of pain therapeutic innovations in palliative care? • Can we learn from health economic models in pain from other areas include

extensive government intervention? This workshop aims to investigate the opportunities and possibilities of Health economic models in pain therapy. Workshop format

• The target audience for this workshop will be health technology authorities, purchase managers and policy makers.

• The format will be interactive with different key note speakers representing different angles of using health economic models in pain.



• A description of the challenge: how can health economic models be useful for decision making in pain related issues?

• A statement to the usefulness of health economic models in pain.


Workshop 5, Cost related to pain Chronic pain and the measurement of its impact on healthcare and society Pain is a symptom that accompanies many diseases. As such pain is often treated in the context of these co-morbidities. In most EU-countries decision makers on health care budgets usually do not have access to robust data showing the societal impact of pain. Pain and chronic pain as such are seldom reflected in the health care budgets and policy making. The lack of attention to the management of cost and translation of quality outcomes related to pain potentially leads to an under estimation of its consequences for the quality of life of patients, its contribution to the healthcare budget and its impact on society. This workshop intends to initiate a discussion on the costs related to pain and pain management that policymakers need to be fully aware of in order to develop rational and effective healthcare strategies. The objective of the workshop is to reach consensus on what data is relevant for policymakers and how to make this data available to decision-makers. Examples of topics that will be discussed are3, among others:

• direct costs of interventions and therapies • direct costs that are incurred as a result of ineffective interventions • costs to health service, patients and their families due to lack of appropriate

facilities • costs resulting from inappropriate self-medication and treatment • costs of treating and preventing adverse events • costs of disability claims resulting from people’s inability to work • costs to economy of reductions in productivity and absenteeism • costs of providing social care and support to people suffering with pain (e.g. costs

of home care and respite care) • costs of informal care provided by families (e.g. loss of earnings) • costs of intangibles associated with deterioration in the QOL of patients and their

families • …….. any other relevant costs

Workshop format

• The target audience for the workshops will be policy makers and key decision-makers who are actively involved in health care management projects.

• The format will be interactive with different key note speakers presenting projects and/or case studies relevant to the topic of the workshop.

3 Adapted from: Ceri J. Phillips; 2005; Health Economics: an introduction for health professionals


Following the key note presentations, a facilitated discussion will take place, inviting the audience to come up with ideas and opinions on the topics presented by the speakers


• A description of the challenges as identified in the workshop caused by the impact of chronic pain as a driver of healthcare costs, loss of quality of life and the impact of pain on society

• A proposal for next steps that need to be taken to enable decision-makers to meet these challenges


Workshop 6, Light house projects (“best practice”) Large scale longitudinal data on pain outcomes available to decision makers and policy makers are rare. In several countries projects have been initiated aiming to gain insight in the issues related to pain and costs caused by pain. These are expected to deliver the facts and figures like prevalence, demographics, quality measurement, cost and resources related to the impact of pain on society. This workshop intends to share the insight of some light house projects in order to create a platform for sharing “best practices”.

Workshop format

• The target audience for this workshop will be policy makers and health care managers planning to initiate or actively being involved in health care management projects focussed on pain.

• The format will be interactive with different key note speakers representing different light house projects in retrieving and analysing longitudinal data related to pain.


Workshop deliverables Based on the workshop, a symposium paper will be produced that will cover:

• A description of the challenge: how can data available be utilized for decision making in pain related issues?

• A statement to the usefulness of longitudinal data for strategic decision making in pain..


Organisation

Program Steering Committee The symposium objectives and topics where prepared for the EFIC® by the program Steering Committee on “Societal Impact of Pain” consisting out of: Juan Manuel Collar, Dr. Günther Danner, Dr. Gottfried Endel, Norman Evans, Prof. Guido Fanelli, Betty Flynn, Alison Given, Dr. Christoph Gries, Sarah Griffin, Dr. Alberto Grua, Rainer Henske, Dr. Albrecht Kloepfer, Dr. Julio López Bastida, Dr. Pete MacKenzie, Celia Manson, Dr. Villy Meineche Schmidt, Doris Ney, Anna Nys, Dr. oec. HSG Willy Oggier, Prof. Narinder Rawal, Ad Rietveld, Dr. Alain Serrie, Wil Toenders, Keith Tolley, Prof. Giustino Varrassi, Norbert van Rooij, Heather Wallace

Scientific responsibility

EFIC® (European Federation of IASP Chapters Medialaan 24 1800 Vilvoorde Belgium Weblink: http://www.efic.org

Meeting Logistics R-Events E-mail: [email protected] Fax: + 32 3 544 7880 Tel: +32 473 291 361

Sponsor

Grünenthal GmbH Zieglerstraße 6 52078 Aachen GERMANY


Registration Due to the limited amount of available places registration is restricted to active health care budget holders, health care policy makers and strategic health care decision makers for the area of pain and pain treatment. In order to secure participation early registration is strongly advised.

Participant registration Registration fee: 250 € (excluding accommodation) Online registration: www.regonline.com/efic-may-symposium If you have any questions, please contact Randa Becker at [email protected] or tel: +32 473 291 361. You will be contracted shortly after your registration submission to confirm your attendance and discuss payment options.

MDEON visumnummer For Belgium participants MDEON Visa number: 10/V1/2450/025617.

Accommodation We currently have a room block at the symposium venue Hotel LaHulpe where the event is being held. The agreed rate is currently 150€ + VAT (bed and breakfast – double room for single occupancy). Please note that this rate is on an allocation basis only. Following the availability, the hotel will offer the best available rate at the time of booking. Please note that all costs incurred during your stay are your responsibility. If you have any questions, please contact Randa Becker at [email protected] or tel: +32 473 291 361.

Speaker registration Registration fee: No fee is required for participants who have an active role in the symposium (e.g. speakers, moderators, workshop reporters or poster presenters) Online registration: www.regonline.com/efic-may-speaker If you have any questions, please contact Randa Becker at [email protected] or tel: +32 473 291 361. You will be contracted shortly after your registration submission to confirm your attendance.


Speaker Information All speakers are requested to deliver their presentation 15 minutes prior to the session start time at latest to R-Events. All presentations submitted to R-Events by the specified advance deadline are pre-loaded onto the session room computer. If you did not submit your presentation in advance bring your presentation on a USB/flash drive and R-Events staff will assist you with loading your presentation.

Language The meeting language for presentations, workshops and discussions is English.


Poster presentation Information There will be limited possibility to present posters. For more information please contact R-Events

Exhibitor Opportunities There will be limited possibility to present your organisation and services to a European representation of the top healthcare decision-makers from a variety of pain related environments including, clinical practice, government agencies, academia and managed care. For more information please contact R-Events


The venue: Dolce La Hulpe Dolce La Hulpe Brussels is located in the heart of the ancient Sonian forest creating a tranquil and verdant sanctuary only minutes from the Brussels City Centre and Brussels International Airport. Hotel Dolce La Hulpe 135, Chaussée de Bruxelles, 1310 La Hulpe BELGIUM Phone: +32 (0)2 290 98 00 http://www.dolce-la-hulpe-brussels-hotel.com


About EFIC The European Federation of IASP chapters (EFIC) is a multidisciplinary professional organization in the field of pain science and medicine, made up of the 34 European Chapters of IASP (International Association for the Study of Pain). Established in 1993, by Prof. Ulf Lindblom, the EFIC® represents 34 countries and close to 20.000 scientists, physicians, nurses, physiotherapists, psychologists and other healthcare professionals across Europe, who study pain and treat patients in pain. Mission Statement The European Federation of IASP Chapters (EFIC) was formed by the presidents of the European Chapters at a joint meeting held at the time of the World Congress on Pain, in Paris in August, 1993. Aims The objectives of the EFIC® are in general those of IASP, i.e. to promote research, education, and the clinical management of pain. The specific aim is to create a forum for European collaboration on pain issues and to encourage communication at a European level between IASP Chapters, and also with other bodies interested or involved in the fields of pain research and therapy such as the European societies or federations of medical specialities (anaesthesiology, neurology, headache, palliative care etc.), institutions of the European Community, European and national educators and legislators. Examples of pain issues that may be dealt with by EFIC:

• The epidemiology of acute and chronic pain in Europe. • The availability of pain treatment facilities. • The interface between patient needs and treatment facilities. • The recognition of differences in therapeutic strategies and pain education within

Europe. • The harmonisation of such differences. • Review of existing curricula and plans for training of pain specialists • (it might be desirable to develop a European academy to accredit pain

specialists, possibly by examination). • Setting standards for diagnosis and treatment of chronic pains of different types

and mechanisms. Constitution The affairs of EFIC® are conducted by its Council, which consists of the Presidents of the European IASP Chapters, and five elected officers who form the Executive Board. The Council meets once a year while the Board manages affairs between meetings. EFIC® is established as a charitable foundation in Belgium.


EFIC's position in relation to IASP The bylaws of the IASP (section V) provide that national Pain Societies and Associations may constitute Chapters of the IASP in their country. The EFIC® acts as a European grouping of these Chapters of the IASP, so that they may work together while allowing for the socio-cultural diversity of Europe. Many of the societies have a large percentage of members who are not members of IASP; they are, none-the-less, members of EFIC® and will benefit from the wider perspectives offered by a trans-national organisation. Specific programmes EFIC® co-operates in the organisation of Congresses, such as those in Verona, Italy, in May 1995 in Barcelona, Spain, in 1997, in Nice, France in 2000, in Prague, Czech Republic in 2003, in Istanbul, Turkey 13-16 2006, Lisbon, Portugal in 2009 and upcoming in Hamburg, Germany in September 21-24 2011. EFIC® produces an electronic newsletter which is distributed by an email database list to the Chapters and to all their members and is available on the website and is involved with the production of the European Journal of Pain. Under EFIC® auspices, Task Forces are working on aspects of pain research and management, and their findings will be used to improve education and training throughout Europe.

draft program - may 4th & 5th...

Documents